Somewhere around a $500M MC is reasonable considering everything achieved and pipelines and the IP and licensing.
Well, moron, that's what happens when there is a concerted short and distort campaign going on. You of all people know all about that maneuver.
As if we expected an actual answer from a troll. So it stands there is no " distribution."
Any opinion on the general state of the company and on the status of the FDA relationship and speculation on the cervical trial prognosis?
What "distribution" are you referring to? There is nothing being distributed.
The deaths of two patients were deemed not relevant by all of the involved medical professionals, review board, and FDA concurred with the findings, which is why there was no medical halt on the study. The only halts were administrative due to modifications.
Why would anybody continue to discuss and even bring up old news of irrelevant deaths. They were barely discussed in real time and have had zero effect on the stock and zero influence upon the FDA. The only thing relevant right now is a poorly managed clinical trial (apparently going to be addressed) and poor communications and decisions by a very disappointing CEO.
Let's focus on real issues instead of elevating things having zero significance.
Yes Mark. You get paid a lot more than many of us retail investors. Put your money where your mute mouth is and buy shares.
And we went green since there wasn't any manipulation. The manipulation comes from an entity that wants to suppress the share price. An opportunistic short is smarter. They would rather pump it and then short from a higher price point. This is all good since the SEC is investigating the manipulative shorting. Hopefully they will nail the perpetrators soon. Anavex investors have been harmed by these nefarious people.